Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Tonini

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Cancer Research|September 1, 1987
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562G P Tonini, D Radzioch, A Gronberg, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1987
N-myc oncogene amplification in a patient with IV-S neuroblastomaG P Tonini, G Verdona, B De Bernardi, et al.
Genes, Chromosomes & Cancer|September 1, 1996
Peculiar allelotype associated with susceptibility to neuroblastomaP Perri, A Pession, K Mazzocco, et al.
Cancer Genetics and Cytogenetics|February 1, 1988
Cytogenetic and molecular study of two human neuroblastoma cell linesE Donti, L Longo, G P Tonini, et al.
British Journal of Haematology|September 1, 1979
Haemophilia 'A' in a 46,X,i(Xq) femaleP G Mori, M Pasino, C R Vadalà, et al.
Cancer Letters|July 16, 1990
Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell lineD Di Martino, C Avignolo, B Marsano, et al.
International Journal of Cell Cloning|July 1, 1986
EBNA-negative polyclonal B cells derived from a long-term culture of unclassified acute lymphoblastic leukemia: IL-2-like activity of culture's supernatantM T Parodi, M Baffico, G P Tonini, et al.
Nanotechnology|March 12, 2010
DNA-functionalized solid state nanopore for biosensingV Mussi, P Fanzio, L Repetto, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2008
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastomaC Perfumo, S Parodi, K Mazzocco, et al.
British Journal of Cancer|March 29, 2000
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomasA Iolascon, L Giordani, A Borriello, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Cancer Research|September 1, 1987
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562G P Tonini, D Radzioch, A Gronberg, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1987
N-myc oncogene amplification in a patient with IV-S neuroblastomaG P Tonini, G Verdona, B De Bernardi, et al.
Genes, Chromosomes & Cancer|September 1, 1996
Peculiar allelotype associated with susceptibility to neuroblastomaP Perri, A Pession, K Mazzocco, et al.
Cancer Genetics and Cytogenetics|February 1, 1988
Cytogenetic and molecular study of two human neuroblastoma cell linesE Donti, L Longo, G P Tonini, et al.
British Journal of Haematology|September 1, 1979
Haemophilia 'A' in a 46,X,i(Xq) femaleP G Mori, M Pasino, C R Vadalà, et al.
Cancer Letters|July 16, 1990
Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell lineD Di Martino, C Avignolo, B Marsano, et al.
International Journal of Cell Cloning|July 1, 1986
EBNA-negative polyclonal B cells derived from a long-term culture of unclassified acute lymphoblastic leukemia: IL-2-like activity of culture's supernatantM T Parodi, M Baffico, G P Tonini, et al.
Nanotechnology|March 12, 2010
DNA-functionalized solid state nanopore for biosensingV Mussi, P Fanzio, L Repetto, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2008
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastomaC Perfumo, S Parodi, K Mazzocco, et al.
British Journal of Cancer|March 29, 2000
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomasA Iolascon, L Giordani, A Borriello, et al.
Pageof 8